Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1389.037
  • -24.179-1.71%
Close Mar 31 16:00 ET
1397.421High1355.479Low
Constituent Stocks: 10Top Rising: BLUE+19.61%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
BLUEbluebird bio
4.8800.800+19.61%3.64M18.50M4.4254.0805.4204.41047.78M47.45M9.79M9.72M+24.49%+23.23%+25.77%-41.49%-57.19%-80.32%-41.49%--37.46%LossLoss24.76%Biotechnology
AAgilent Technologies
116.9800.290+0.25%2.01M234.46M116.360116.690117.730113.76033.35B33.24B285.10M284.12M-4.09%-4.50%-7.40%-12.92%-19.16%-19.21%-12.92%0.82%0.71%26.8326.413.40%Diagnostics & Research
VRTXVertex Pharmaceuticals
484.820-7.870-1.60%2.23M1.08B487.125492.690487.125471.500124.50B124.11B256.79M255.99M-5.26%-5.63%+0.31%+20.39%+6.48%+15.30%+20.39%--0.87%LossLoss3.17%Biotechnology
CRBUCaribou Biosciences
0.913-0.026-2.77%1.16M1.06M0.9070.9390.9430.88984.92M76.64M93.00M83.94M-10.48%-10.48%-14.66%-42.57%-51.17%-81.92%-42.57%--1.38%LossLoss5.76%Biotechnology
EDITEditas Medicine
1.160-0.090-7.20%2.12M2.48M1.2401.2501.2401.15096.25M95.84M82.98M82.62M-16.55%-17.73%-34.46%-8.66%-65.68%-84.07%-8.66%--2.57%LossLoss7.20%Biotechnology
CRSPCRISPR Therapeutics
34.030-2.960-8.00%3.97M134.91M35.75036.99035.75032.9602.92B2.87B85.77M84.34M-20.15%-20.53%-19.53%-13.54%-24.99%-50.09%-13.54%--4.71%LossLoss7.54%Biotechnology
APLSApellis Pharmaceuticals
21.870-2.400-9.89%2.40M53.24M23.67024.27023.99521.7002.75B1.84B125.52M84.23M-9.85%-12.90%-9.10%-31.46%-20.50%-63.37%-31.46%--2.84%LossLoss9.46%Biotechnology
NTLAIntellia Therapeutics
7.110-0.960-11.90%6.68M47.76M7.6908.0707.8306.975736.01M696.16M103.52M97.91M-23.63%-25.78%-24.76%-39.02%-60.48%-73.88%-39.02%--6.82%LossLoss10.60%Biotechnology
BEAMBeam Therapeutics
19.530-2.680-12.07%5.74M110.72M21.24522.21021.38018.3001.95B1.68B99.84M85.92M-18.66%-20.35%-22.19%-21.25%-16.57%-40.20%-21.25%--6.68%LossLoss13.87%Biotechnology
SGMOSangamo Therapeutics
0.656-0.164-20.02%13.63M9.43M0.7800.8200.7900.640147.36M143.50M224.71M218.82M-24.62%-35.07%-28.76%-35.71%-16.03%+7.93%-35.71%--6.23%LossLoss18.33%Biotechnology

News

Comments

Read more